- Home
- PASG vs NYC Comparison
PASG vs NYC Comparison
Compare PASG & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- NYC
- Stock Information
- Founded
- PASG 2017
- NYC 2013
- Country
- PASG United States
- NYC United States
- Employees
- PASG N/A
- NYC N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- PASG Health Care
- NYC Finance
- Exchange
- PASG Nasdaq
- NYC Nasdaq
- Market Cap
- PASG 31.1M
- NYC 27.6M
- IPO Year
- PASG 2020
- NYC N/A
- Fundamental
- Price
- PASG $0.34
- NYC $11.33
- Analyst Decision
- PASG Strong Buy
- NYC
- Analyst Count
- PASG 3
- NYC 0
- Target Price
- PASG $7.67
- NYC N/A
- AVG Volume (30 Days)
- PASG 192.0K
- NYC 9.2K
- Earning Date
- PASG 05-13-2025
- NYC 05-09-2025
- Dividend Yield
- PASG N/A
- NYC N/A
- EPS Growth
- PASG N/A
- NYC N/A
- EPS
- PASG N/A
- NYC N/A
- Revenue
- PASG N/A
- NYC $61,570,000.00
- Revenue This Year
- PASG N/A
- NYC $8.40
- Revenue Next Year
- PASG N/A
- NYC $1.62
- P/E Ratio
- PASG N/A
- NYC N/A
- Revenue Growth
- PASG N/A
- NYC N/A
- 52 Week Low
- PASG $0.30
- NYC $5.46
- 52 Week High
- PASG $1.64
- NYC $13.59
- Technical
- Relative Strength Index (RSI)
- PASG 41.07
- NYC 51.31
- Support Level
- PASG $0.31
- NYC $11.13
- Resistance Level
- PASG $0.40
- NYC $11.70
- Average True Range (ATR)
- PASG 0.05
- NYC 0.98
- MACD
- PASG 0.00
- NYC -0.05
- Stochastic Oscillator
- PASG 30.00
- NYC 45.72
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.